rs41313952
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000344683.10(MCPH1):āc.664T>Cā(p.Cys222Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000427 in 1,602,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000344683.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCPH1 | NM_024596.5 | c.664T>C | p.Cys222Arg | missense_variant | 7/14 | ENST00000344683.10 | NP_078872.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCPH1 | ENST00000344683.10 | c.664T>C | p.Cys222Arg | missense_variant | 7/14 | 1 | NM_024596.5 | ENSP00000342924 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000426 AC: 106AN: 249098Hom.: 0 AF XY: 0.000407 AC XY: 55AN XY: 135156
GnomAD4 exome AF: 0.000433 AC: 628AN: 1449824Hom.: 0 Cov.: 28 AF XY: 0.000446 AC XY: 322AN XY: 722120
GnomAD4 genome AF: 0.000368 AC: 56AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74498
ClinVar
Submissions by phenotype
Microcephaly 1, primary, autosomal recessive Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 30, 2021 | - - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2017 | A variant of uncertain significance has been identified in the MCPH1 gene. The C222R variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The C222R variant is observed in 6/6552 (0.09%) alleles from individuals of Finnish background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The C222R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved, and in silico analysis predicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 22, 2014 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2020 | The c.664T>C (p.C222R) alteration is located in exon 7 (coding exon 7) of the MCPH1 gene. This alteration results from a T to C substitution at nucleotide position 664, causing the cysteine (C) at amino acid position 222 to be replaced by an arginine (R). Based on data from the Genome Aggregation Database (gnomAD) database, the MCPH1 c.664T>C alteration was observed in 0.04% (118/280498) of total alleles studied, with a frequency of 0.26% (27/10354) in the Ashkenazi Jewish subpopulation. This amino acid position is poorly conserved in available vertebrate species. The p.C222R alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at